1,276
Participants
Start Date
September 8, 2020
Primary Completion Date
September 8, 2026
Study Completion Date
September 8, 2030
Limited cancer screening
"The limited cancer screening will include: 1) a complete medical history and physical examination; 2) complete blood count; 3) liver function tests (AST, ALT, ALP, bilirubin); and 4) chest X-ray.~In women, a breast examination, Pap smear/pelvic examination (if \< 70 years old and previously sexually active) and mammogram will be performed, if not conducted in last year.~In men, similarly, prostate examination and PSA testing will be performed, if not conducted in the last year.~All patients will undergo colon cancer screening as per local practice."
Limited cancer screening + FDG PET/CT
The limited cancer screening (as described above) in combination with a FDG PET/CT.
RECRUITING
CH des Pays de Morlaix, Morlaix
NOT_YET_RECRUITING
University of Calgary, Calgary
NOT_YET_RECRUITING
University of Manitoba, Winnipeg
NOT_YET_RECRUITING
McMaster University, Hamilton
NOT_YET_RECRUITING
London Health Sciences Centre, London
RECRUITING
Hopital Montfort, Ottawa
RECRUITING
Ottawa Hospital Research Institute, Ottawa
RECRUITING
Sunnybrook Research Institute, Toronto
RECRUITING
University Health Network, Toronto
RECRUITING
Jewish General Hospital, Montreal
NOT_YET_RECRUITING
McGill University Health Centre, Montreal
RECRUITING
CH Agen, Agen
RECRUITING
CHU Angers, Angers
RECRUITING
Brest University Hospital, Brest
RECRUITING
CHU de Clermont-Ferrand, Clermont-Ferrand
RECRUITING
CHU de Dijon, Dijon
RECRUITING
CHU de Limoges, Limoges
RECRUITING
Hôpital Européen Georges Pompidou, Paris
RECRUITING
CHU Saint-Etienne, Saint-Etienne
RECRUITING
Hôpital Saint Musse - CH Toulon, Toulon
Collaborators (1)
Ministry of Health, France
OTHER_GOV
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Ottawa Hospital Research Institute
OTHER
University Hospital, Brest
OTHER